1. Catalogs
  2. TT Medical
  3. EverFlow® Paclitaxel Coated PTCA Balloon Catheter

EverFlow® Paclitaxel Coated PTCA Balloon Catheter
1 /8Pages

EverFlow® Paclitaxel Coated PTCA Balloon Catheter

EverFlow® Paclitaxel Coated PTCA Balloon Catheter
1 /8Pages

Catalog excerpts

EverFlow® Paclitaxel Coated PTCA Balloon Catheter-1

Efficient Drug Delivery & Proven Efficacy

 Open the catalog to page 1
EverFlow® Paclitaxel Coated PTCA Balloon Catheter-2

- Drug Delivery Specific Balloon Catheter(VesTraveler®): designed specifically fordrugand stent delivery with features of semi-compliant, excellentcrossability and precision balloon expansion. - Special HighBind® Coating Technology: Uniformly 100% surface coating, precision drug loadingand controlled drug release profile. - Evidence-driven of Medicine: minimum drug loss during delivery and controlled release profile during balloon expansion. - Proven Long-last vessel drug retention and efficacy: effective d rug dose remain in vessel upto30days post balloon expansion.

 Open the catalog to page 2
EverFlow® Paclitaxel Coated PTCA Balloon Catheter-3

Drug Balloons EverFlowPaclitaxel Coated PTCA Balloon Catheter Uniformly 100% Balloon Surface Coating Proven Long-lastingVessel Drug Retention & Efficacy Precision Drug Loading Contorlled Drug Release: • Better Drug Adhesion • High DrugTransferto Vessel

 Open the catalog to page 3
EverFlow® Paclitaxel Coated PTCA Balloon Catheter-4

QCA and Histomorphometric comparison between SeQuent® & EverFlow® in porcine coronary arteries 90days post expansion: there are no significant different. (LA: lumen Area; 1EA: internal Elastic Area; MA: Media Area; NlA: Neointima Area; RFD: vessel referencediameter; MLD: minimal lumen diameter, Lumen loss(%DS)=LLL/MLD postx 100%. (inside Data)).

 Open the catalog to page 4
EverFlow® Paclitaxel Coated PTCA Balloon Catheter-5

© EverFlow® Evidence-Driven Device Safety and Efficacy Arterial Drug Concentration Post EverFlow Expansion Coronary Vessel Paclitaxel Residual Dosage: Sufficient and remain up to 35 days post balloon expansion (Paclitaxel safe & efficacy concentration: 0.0085-0.85ug/ml. Axel et al: Circulation.1997; 96:636-645; Sol lot et at; J.Clin.Invest. 1995; 95:1869-1876) EverFlow® PK Data: Paclitaxel (PTX) was detected only within one week in the core organs post balloon expansion, and within safe range (Inside data).

 Open the catalog to page 5
EverFlow® Paclitaxel Coated PTCA Balloon Catheter-6

- De novo lesions (primary use in the case of stenosis or occlusion) including small vessels (SVD) - Residual stenosis after balloon or stent PTCA - Pre and post dilatation during coronary stent implantation - Acute or impending vascular occlusion Material required to perform a PTCA balloon catheter procedure: - Rapid Exchange PTCA catheter - Guiding catheter - Inflation syringe with gauge - Introduction lock set with dilator - Contrast medium - Y-connectorwith haemostatic adapter Prior to use, it is essential that all the instruments, catheters and individual components are carefully checked....

 Open the catalog to page 6
EverFlow® Paclitaxel Coated PTCA Balloon Catheter-8

o Better everyday o Manufacturer: TT Medical, Inc. Rm. 501, Bldg. l,Songshan Lake National High-Tech Park, Dongguan, Guangdong, E-mail: [email protected] Document No.: TT-PTCA-PCB-BR-EN Rev.1.0 Approval Date: 2025.09.01

 Open the catalog to page 8
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.